滚动资讯
FierceBiotech‘M&A used to be the only way to go’: Why Seaport’s CEO opted for route to upsized $255M IPOEndpoints NewsQ&A: Seaport CEO and CSO on learning from Karuna and the future of CNS researchBioPharma DiveSummit’s ‘self-inflicted’ stumble; Esperion’s take-private dealBioPharma DiveModerna sees revenue bump from international COVID vaccine salesEndpoints NewsSamsung Biologics workers begin five-day strike over wage disputesFierceBiotechSummit的PD-1xVEGF中期试验结果不及预期,令分析师意外,股价应声下跌Endpoints NewsAcelyrin创始人Shao-Lee Lin现身Cue,后者成为最新一家从中国获得许可的公司Endpoints News定档通知:Premium订阅用户专属的Post-Hoc直播活动Endpoints NewsFDA批准阿尔茨海默病躁动药物;Esperion以11亿美元私有化交易BioWorld皮肤科专业公司Leo Pharma斥资5000万美元进军基因疗法领域BioPharma Dive百时美施贵宝的旧药翻红,渤健的前景光明,再生元的展望不明FierceBiotechCBER主任普拉萨德卸任,副主任接任,继任者仍在寻找中

资讯库

总数 9804
页码 494 / 545
搜索 --